Free Trial
NASDAQ:AEMD

Aethlon Medical (AEMD) Stock Price, News & Analysis

$0.34
+0.00 (+0.03%)
(As of 09:29 AM ET)
Today's Range
$0.34
$0.34
50-Day Range
$0.34
$0.69
52-Week Range
$0.34
$3.78
Volume
51,053 shs
Average Volume
2.08 million shs
Market Capitalization
$4.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Aethlon Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,931.3% Upside
$7.00 Price Target
Short Interest
Healthy
5.40% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.59 out of 5 stars

AEMD stock logo

About Aethlon Medical Stock (NASDAQ:AEMD)

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

AEMD Stock Price History

AEMD Stock News Headlines

New Government Policy to Wipe Out Seniors Wealth
Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.
Why Is Aethlon Medical (AEMD) Stock Up 82% Today?
New Government Policy to Wipe Out Seniors Wealth
Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.
Aethlon Medical Inc
Aethlon Medical Inc (AEMD)
See More Headlines
Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/27/2024
Today
7/25/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:AEMD
Fax
N/A
Employees
15
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+1,931.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-12,210,000.00
Pretax Margin
-2,133.97%

Debt

Sales & Book Value

Annual Sales
$570,000.00
Book Value
$2.19 per share

Miscellaneous

Free Float
13,344,000
Market Cap
$4.79 million
Optionable
No Data
Beta
1.64
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Guy F. Cipriani BS (Eng.) (Age 53)
    MBA, Chief Operating Officer
    Comp: $347.5k
  • Dr. Steven P. LaRosa M.D. (Age 57)
    Chief Medical Officer
    Comp: $430k
  • Mr. James B. Frakes M.B.A. (Age 67)
    Interim CEO, CFO, Secretary & Director
    Comp: $385k
  • Dr. Lee D. Arnold Ph.D. (Age 64)
    Chief Scientific Officer

AEMD Stock Analysis - Frequently Asked Questions

How have AEMD shares performed this year?

Aethlon Medical's stock was trading at $2.19 at the start of the year. Since then, AEMD shares have decreased by 84.3% and is now trading at $0.3446.
View the best growth stocks for 2024 here
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) released its quarterly earnings results on Thursday, June, 27th. The medical equipment provider reported ($0.91) EPS for the quarter, beating analysts' consensus estimates of ($1.18) by $0.27.

When did Aethlon Medical's stock split?

Aethlon Medical's stock reverse split before market open on Thursday, October 5th 2023. The 1-10 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Aethlon Medical's major shareholders?

Top institutional shareholders of Aethlon Medical include Concourse Financial Group Securities Inc..
View institutional ownership trends
.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP) and Novavax (NVAX).

This page (NASDAQ:AEMD) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners